DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE
摘要
<p>The presently disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin and enzyme replacement therapy for the treatment of Fabry disease. The presently disclosed subject matter further provides a dosing regimen and administration schedule for the use of migalastat hydrochloride and agalsidase for the treatment of Fabry disease.</p>
申请公布号
SG193379(A1)
申请公布日期
2013.10.30
申请号
SG20130067954
申请日期
2012.03.08
申请人
AMICUS THERAPEUTICS, INC.
发明人
GREENE, DOUGLAS, STUART;VALENZANO, KENNETH, JOSEPH